Biogen Idec admits defeat to Icahn in board contest
This article was originally published in Scrip
Executive Summary
Biogen Idec has confirmed that its shareholders have elected two of dissident investor Carl Icahn's nominees to its board, after a week of delays and recounts by the biotech company.